In addition, effective treatment of wild‐type GIST suggested that inhibition of SRC or downstream signaling pathways of KIT could play another important role in the treatment of drug‐resistant GIST with dasatinib. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.